SCHEMBL4366038

SCHEMBL4366038

COC(=O)C(Cc1ccc(OC(F)(F)F)cc1)NC(C)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 3/20 0.60
FPR2 P25090 1/20 0.50
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
NOS3 P29474 2/20 0.46
NOS1 P29475 2/20 0.46
NOS2 P35228 2/20 0.46
PPARG P37231 3/20 0.46
EPHX2 P34913 2/20 0.46
PPARA Q07869 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
TSHR P16473 1/20 0.44
MDM4 O15151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6775559 1.00 ACACB (0.60) ACACBFPR2ALDH1A1HPGDNOS3
SCHEMBL6781722 0.88 FPR2 (0.64) ACACBFPR2PPARGEPHX2PPARA
SCHEMBL4378290 0.88 FPR2 (0.64) ACACBFPR2PPARGEPHX2PPARA
SCHEMBL2722182 0.85 KLK5 (0.53) ACACBFPR2ALDH1A1PPARGPPARA
SCHEMBL6662892 0.84 ACACB (0.58) ACACBFPR2ALDH1A1PPARGKMT2A
SCHEMBL5706152 0.84 ACACB (0.58) ACACBFPR2ALDH1A1PPARGKMT2A
SCHEMBL6771309 0.84 ACACB (0.49) ACACBALDH1A1NOS3NOS1NOS2
SCHEMBL2854764 0.83 ALDH1A1 (0.46) ALDH1A1NOS3NOS1NOS2PPARG
SCHEMBL2854766 0.83 ALDH1A1 (0.46) ALDH1A1NOS3NOS1NOS2PPARG
SCHEMBL863032 0.82 KMT2A (0.51) ACACBALDH1A1NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968172-B2 USP30 inhibitors MITOBRIDGE, INC. (US) 2021-04-06 US disclosed
US-20200131121-A1 USP30 INHIBITORS Astellas Engineered Small Molecules US, Incorporated 2020-04-30 US disclosed
EP-1908466-B1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO CO LTD (JP) 2014-02-19 EP disclosed
US-8344029-B2 Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-01-01 US disclosed
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-26 US disclosed
CN-101267813-A Substituted propanamide derivative and pharmaceutical composition containing the same DAIICHI SANKYO CO LTD (JP) 2008-09-17 CN disclosed
EP-1908466-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968172-B2 USP30 inhibitors USP30, UBQLN1, UBQLN2 ACACB 2404/4885FPR2 4744/4885ALDH1A1 1359/4885
US-20090292024-A1 SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME PTMS, C1S, ACP3 ACACB 735/4885FPR2 3587/4885ALDH1A1 298/4885
US-20200131121-A1 USP30 INHIBITORS USP30, UBQLN1, UBQLN2 ACACB 2404/4885FPR2 4744/4885ALDH1A1 1359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.